NIH-funded research R01 grant

Noninvasive brain stimulation to improve word‑finding in primary progressive aphasia

Official title: Phase II clinical trial of transcranial direct current stimulation in the treatment of primary progressive aphasia

Funded at University of Pennsylvania · NIH-11378070 · Data updated 2026-11-12

This project uses gentle, noninvasive brain stimulation (tDCS) to try to help people with primary progressive aphasia who have trouble finding words.

More Primary Progressive Aphasia research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 30, 2022
Project endMay 31, 2027
Funding year2025
Award (this year)$241,630
NIH project number3R01AG075111-04S1
Project IDNIH-11378070 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults diagnosed with primary progressive aphasia who are experiencing noticeable word‑finding difficulties and can attend visits at one of the participating sites.

Less likely to help

People without PPA, those with very advanced dementia, or those with medical reasons to avoid brain stimulation (for example uncontrolled seizures or certain implanted devices) are unlikely to benefit or be eligible.

What this research studies

If you join, you would receive short sessions of transcranial direct current stimulation (tDCS) aimed at brain areas involved in naming, combined with language testing and therapy. The trial is randomized, double‑blind, and uses a within‑subject crossover design so participants receive both active and sham (placebo) stimulation at different times. About 120 people with PPA will be enrolled across several major research centers, and researchers will compare language outcomes after the different stimulation sessions. Study visits will include baseline assessments, treatment sessions, and follow‑up language tests to measure any changes.

Why it matters

Potential benefit: If successful, the treatment could reduce word‑finding trouble and improve everyday communication for people with PPA.

How similar studies have gone: Small pilot studies of tDCS in PPA have shown promising signals for improving naming, but evidence is limited and mixed, so this larger, more rigorous trial is needed.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Hamilton, Roy H — University of Pennsylvania
  • Study coordinator: Hamilton, Roy H

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.